30 Participants NeededMy employer runs this trial

AI Chatbot for Young Adult Cancer Survivors

RK
Overseen ByRobert Knoerl
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Michigan Rogel Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This clinical trial studies whether an artificial intelligence (AI)-powered supportive care chatbot is helpful for addressing the supportive care needs of young adult cancer survivors. Young adult cancer survivors often experience ongoing and distressing symptoms following treatment, including extreme tiredness and lack of energy, anxiety, and difficulty sleeping. Young adult cancer survivors report a variety of strategies to self-manage these symptoms; however, there remains a gap in targeted interventions focused on the needs in young adult survivors. The AI-powered supportive care chatbot is designed to provide evidence-based information on supportive care for young adult cancer survivors. Users interact with the chatbot by entering free-text questions or selecting from predefined topics to receive tailored educational responses related to supportive care across the cancer continuum, including treatment effects, symptom management, care transitions, and life after cancer. The AI-powered supportive care chatbot may be an effective way to help address the supportive care needs of young adult cancer survivors.

Who Is on the Research Team?

RK

Robert Knoerl

Principal Investigator

University of Michigan Rogel Cancer Center

Are You a Good Fit for This Trial?

This trial is for young adults who have survived cancer. Participants should be interested in using a digital tool to help manage ongoing symptoms and supportive care needs after their cancer treatment.

Inclusion Criteria

I am between 18 and 39 years old.
Able to speak/read English
I finished my main cancer treatment over a month ago.
See 3 more

Exclusion Criteria

I finished my cancer treatment over three years ago.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants interact with the AI-powered supportive care chatbot in a self-directed manner

4 weeks
Self-directed use

Optional Extension

Participants may choose to continue using the chatbot for an additional 8 weeks

8 weeks
Self-directed use

Follow-up

Participants are monitored for outcomes such as acceptability, usability, and retention

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Artificial Intelligence-powered Supportive Care Chatbot

Trial Overview

The study is testing an AI-powered chatbot designed to give personalized information and support about managing symptoms, side effects, and life after cancer. Participants will interact with the chatbot, complete surveys, and may take part in interviews.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Supportive care (AI-powered supportive care chatbot)Experimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan Rogel Cancer Center

Lead Sponsor

Trials
303
Recruited
20,700+